KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
KPMG's second annual cash survey has found that companies have pushed cash generation up the agenda in response to the changing demands of analysts, lenders and ratings agencies.
Related links
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.